Scientists Uncover Surprising Insights into Tiny Drug Delivery Capsules
BETHESDA, MD – A groundbreaking study challenges the conventional approach to designing drug delivery systems. Researchers have discovered that the effectiveness of tiny fatty capsules used in COVID-19 mRNA vaccines may be enhanced by embracing a more chaotic structure. This counterintuitive finding emerged from a novel method that allows scientists to examine individual drug-delivery particles, revealing that cramming more medicine into these capsules isn't always beneficial.
Lipid nanoparticles (LNPs) are microscopic fat bubbles that transport delicate RNA molecules into cells, playing a pivotal role in the success of mRNA vaccines. Scientists are now exploring their potential for delivering treatments for cancer, genetic disorders, and other ailments. However, a significant challenge arises: only a meager 1 to 5 percent of the RNA cargo within LNPs is released into cells.
Artu Breuer, a researcher at the University of Copenhagen, highlights the implications of this low efficiency. In rapidly dividing cancer cells, for instance, insufficient RNA delivery can outpace the therapeutic effect. To address this, Breuer and his team developed a high-throughput technique that enables the measurement of individual nanoparticles, up to a million at a time, rather than relying solely on the average properties of a batch.
Their findings were eye-opening. Instead of assuming uniformity, they uncovered a vast variation among nanoparticles. Two distinct subpopulations emerged: organized particles with neatly structured cargo and amorphous particles with a more disorganized structure. Surprisingly, the disorganized particles demonstrated superior performance inside cells.
This discovery challenges the traditional approach of maximizing medicine loading and packing efficiency. Drug developers have focused on creating highly organized particles, akin to the layers of an onion, which may inadvertently resist releasing their cargo once inside cells. In contrast, the disorganized particles, with their separated charges, are more susceptible to disintegration when conditions change inside the cell, leading to the release of the medicine.
The research suggests a paradigm shift in the design of these delivery systems. Instead of prioritizing the maximum cargo capacity, scientists might need to focus on maintaining a disorganized internal structure that facilitates the release of the cargo once it reaches its destination. Breuer emphasizes that while they don't advocate for empty nanoparticles, finding a balance between RNA loading and preserving the disorganized structure is crucial for improved cellular delivery.
The team's innovative single-nanoparticle measurement tool provides researchers with a powerful screening method to evaluate LNP formulations and identify the structural features that significantly impact delivery efficiency. This advancement has the potential to accelerate the development of more effective RNA-based medicines, marking a significant step forward in the field of drug delivery.
